Similar Articles
-
Abstract C-C1-04: The Effectiveness of Diabetes Care Management in a Large, Integrated Delivery System: a TRIAD Study
Julie A. Schmittdiel, Connie Uratsu, Bruce Fireman and Joe V. Selby- Clinical Medicine & Research December 2008, 6 (3-4) 125;
- DOI: https://doi.org/10.3121/cmr.6.3-4.125-a
-
Abstract PS2-18: Patient-Provider Communication About Prescription Drug Costs Among Medicare Part D Beneficiaries
Vicki Fung, Mary Price and John Hsu- Clinical Medicine & Research December 2008, 6 (3-4) 146;
- DOI: https://doi.org/10.3121/cmr.6.3-4.146-b
-
PS2-04: Impact of Medication Therapy Management Delivered to Home-based Medicare Beneficiaries
Thomas Delate, Elizabeth Chester, Erin Welch and Troy Stubbings- Clinical Medicine & Research March 2010, 8 (1) 57;
- DOI: https://doi.org/10.3121/cmr.8.1.57-b
-
PS2-11: Characteristics of Medicare Part D Beneficiaries Who Obtain Prescriptions at Pharmacies External to Their Health Plan
Anna Hoai Thuong T Nguyen, Jennifer L Ellis, Thomas Delate and Marsha A Raebel- Clinical Medicine & Research March 2010, 8 (1) 58;
- DOI: https://doi.org/10.3121/cmr.8.1.58-a
-
Plenary III–04: Responses to Drug Costs: Year Three of the Medicare Part D Program
Vicki Fung, Mary Reed and John Hsu- Clinical Medicine & Research December 2010, 8 (3-4) 209;
- DOI: https://doi.org/10.3121/cmr.2010.943.plenary-iii-04
-
PS2-36: Incremental Medical Care Costs of Prostate Cancer for Medicare Beneficiaries
Mark Hornbrook, Paul Fishman, Debra Ritzwoller, Jennifer Lafata, Maureen O’Keeffe-Rosetti, Ramzi Salloum, Jenny Staab and Erin Keast- Clinical Medicine & Research September 2014, 12 (1-2) 80;
- DOI: https://doi.org/10.3121/cmr.2014.1250.ps2-36
-
CB7-02: Medicare Part D Cost-sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems
Vicki Fung, Mary Price, Alisa Busch, William Dow, Bruce Fireman, Rita Hui, Mary Beth Landrum, Richard Frank, Joseph Newhouse and John Hsu- Clinical Medicine & Research August 2012, 10 (3) 182;
- DOI: https://doi.org/10.3121/cmr.2012.1100.cb7-02
-
PS2-17: Characteristics of Medicare Beneficiaries Who Repeatedly Reach the Drug Benefit Threshold
Elizabeth A Bayliss, Jennifer L Ellis, Tom Delate, John F Steiner and Marsha A Raebel- Clinical Medicine & Research March 2010, 8 (1) 58-59;
- DOI: https://doi.org/10.3121/cmr.8.1.58-c
-
PS2-18: Functional Limitations, Home Support, and Responses to Drug Costs Among Medicare Beneficiaries
Christopher Whaley, Mary Reed, John Hsu and Vicki Fung- Clinical Medicine & Research September 2013, 11 (3) 159-160;
- DOI: https://doi.org/10.3121/cmr.2013.1176.ps2-18
-
Abstract PS1-16: A Study Design to Evaluate Group Dialogue Activities to Improve Diabetes Outcomes
JoAnn M. Sperl-Hillen, Sarah J. Beaton, Adrine Chung, Ann Von Worley and Jodi Lavin-Tompkins- Clinical Medicine & Research December 2008, 6 (3-4) 133-134;
- DOI: https://doi.org/10.3121/cmr.6.3-4.133-c